Clinical features and prognostic factors associated with adrenocortical carcinoma: Lahey clinic medical center experience

American Surgeon

Volumn 66, Issue 1, 2000, Pages 73-79

  Tritos, Nicholas A ^a   Cushing, Gary W ^a   Heatley, Gerald ^a   Libertino, John A ^a  

^a LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADRENAL CORTEX CARCINOMA; ADULT; AGE; AGED; ARTICLE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL FEATURE; FEMALE; HUMAN; MALE; METASTASIS; PROGNOSIS; SCHOOL CHILD; SURVIVAL RATE; UNITED STATES;

ADOLESCENT; ADRENAL CORTEX NEOPLASMS; ADRENOCORTICAL CARCINOMA; ADULT; AGED; CHILD; FEMALE; HUMANS; MALE; MASSACHUSETTS; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 0033987469     PISSN: 00031348     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Barzilay JI, Pazianos AG. Adrenocortical carcinoma. Urol Clin North Am 1989;16:457-68.
2. Biometrics Branch, National Cancer Institute: Third National Cancer Survey: Incidence data. In: Cutler SJ, Young JL, eds. National Cancer Institute Monograph 41. Washington, DC, Government Printing Office, DHEW Publication No (NIH) 75-787, 1975.
3. Norton JA, Doppman JL, Jensen RT. Cancer of the endocrine system. In: De Vita T, Hellman S, Rosenberg SA, eds. Cancer: Principles and Practice of Oncology, 3rd Ed. Philadelphia: JB Lippincott Company, 1989, pp 1269-344.
4. Murphy BE. Some studies of the protein-binding of steroids and their application to the routine micro and ultramicro measurement of various steroids in body fluids by competitive protein-binding radioassay. J Clin Endocrinol Metab 1967;27:973-90.
5. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. Am Stat Assoc J 1958;53:457-81.
6. Tarone RE, Ware J. On distribution-free tests for equality of survival distributions. Biometrika 1977;64:156-60.
7. Cox DR. Regression models and life-tables. J R Stat Soc B 1972;34:187-220.
8. Luton JP, Cerdas S, Billaud L, et al. Clinical features of adrenocortical carcinoma, prognostic factors, and the effect of mitotane therapy. N Engl J Med 1990;322:1195-201.
9. Bodie B, Novick AC, Pontes JE, et al. The Cleveland Clinic experience with adrenal cortical carcinoma. J Urol 1989;141: 257-60.
10. Kay R, Schumacher OP, Tank ES. Adrenocortical carcinoma in children. J Urol 1983;130:1130-2.
11. Bertagna C, Orth DN. Clinical and laboratory findings and results of therapy in 58 patients with adrenocortical tumors admitted to a single medical center (1951 to 1978). Am J Med 1981; 71:855-75.
12. Didolkar MS, Bescher RA, Elias EG, Moore RH. Natural history of adrenal cortical carcinoma: A clinicopathologic study of 42 patients. Cancer 1981;47:2153-61.
13. King DR, Lack EE. Adrenal cortical carcinoma: A clinical and pathologic study of 49 cases. Cancer 1979;44:239-44.
14. Geelhoed GW, Dunnick NR, Doppman JL. Management of intravenous extensions of endocrine tumors and prognosis after surgical therapy. Am J Surg 1980;139:844-8.
15. Wei CY, Chen KK, Chen MT, et al. Adrenal cortical carcinoma with tumor thrombus invasion of inferior vena cava. Urology 1995;45:1052-4.
16. Moul JW, Hardy MR, McLeod DG. Adrenal cortical carcinoma with vena cava tumor thrombus requiring cardiopulmonary bypass for resection. Urology 1991;38:179-83.
17. Concepcion RS, Koch MO, McDougal WS, et al. Management of primary nonrenal parenchymal malignancies with vena caval thrombus. J Urol 1991;145:243-7.
18. Coonrod DV, Rizkallah TH. Virilizing adrenal carcinoma in a woman of reproductive age: A case presentation and literature review. Am J Obstet Gynecol 1995;172:1912-5.
19. Lanigan D, Choa RG, Evans J. A feminizing adrenocortical carcinoma presenting with gynaecomastia. Postgrad Med J 1993; 69:481-3.
20. Puvaneswary M, Thong K. Primary hyperaldosteronism: Due to adrenal cortical carcinoma. Australas Radiol 1993;37:88-9.
21. Zografos GC, Driscoll D, Karakousis C, Huben R. Staging and grading in the survival of adrenal carcinomas. Eur J Surg Oncol 1994;20:449-53.
22. Etxabe J, Vazquez JA. Morbidity and mortality in Cushing's disease: An epidemiological approach. Clin Endocrinol 1994;40:479-84.
23. Nader S, Hickey RC, Sellin RV, Samaan NA. Adrenal cortical carcinoma: A study of 77 cases. Cancer 1983;52:707-11.
24. Haak HR, Hermans J, van de Velde CJ, et al. Optimal treatment of adrenocortical carcinoma with mitotane: Results in a consecutive series of 96 patients. Br J Cancer 1994;69:947-51.